Singapore to Buy Covid Jab From China’s Sinovac Biotech

[TaiShang]

(Yicai Global) Dec. 15 -- Singapore recently signed an advance purchase agreement with Chinese vaccine maker Sinovac Biotech for Covid-19 vaccines, Singapore’s Lianhe Zaobao reported yesterday, but without detailing the number of shots to be supplied.

The Sinovac Biotech inoculants will arrive in batches next year, and Singapore is also in contact with other pharmaceutical companies, per the report.

Beijing-based Sinovac Biotech is promoting Phase III clinical trials of its inactivated vaccine CoronaVac against Covid-19 in Brazil, Indonesia, Turkey and Chile. Indonesia's state-owned pharma firm PT Bio Farma said this month that CoronaVac has proven 97 percent effective in early trials, and its ultimate efficacy rate will be determined next month.

The Sinovac Biotech jab was previously used in emergency inoculations against Covid-19 in Zhejiang in mid-October. On Dec. 7, Sinovac Biotech announced that it had obtained the results of Phase I/II clinical trials on an adult group and an elderly group in China, and started the Phase I/II clinical trials on a juvenile one.

Sinovac Biotech is expanding its production as these tests steadily advance. The firm’s Sinovac Life Sciences unit has secured over USD500 million from Sino Biopharmaceutical for further development, capacity expansion and manufacturing of its CoronaVac Covid-19 vaccine candidate, Sinovac Biotech announced on Dec. 7.

Sinovac Life Sciences has built and put into use a Covid-19 vaccine plant which is able to turn out 300 million vaccine doses annually, per the announcement. The company also plans to complete a second production line before year’s end and raise its annual output of CoronaVac to over 600 million doses.

Sinovac Biotech was China's first vaccine company to list in the US. Its shares [NASDAQ:SVA] rose 0.31 percent yesterday to USD6.47.

Singapore to Buy Covid Jab From China’s Sinovac Biotech

www.yicaiglobal.com

 

[Hamartia Antidote]

Peru suspends Chinese Covid-19 vaccine trial over serious side effects

The National Institute of Health said a volunteer presented neurological symptoms, which could correspond to a condition called Guillain-Barre syndrome.

www.trtworld.com

Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.

The National Institute of Health said on Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.

"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.

Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs.

Peru declared a temporary health emergency in five regions in June last year following multiple cases.

Horrible...wheelchair bound for the rest of your life

 

[CAPRICORN-88]

Peru suspends Chinese Covid-19 vaccine trial over serious side effects

The National Institute of Health said a volunteer presented neurological symptoms, which could correspond to a condition called Guillain-Barre syndrome.

www.trtworld.com

Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.

The National Institute of Health said on Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.

"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.

Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs.

Peru declared a temporary health emergency in five regions in June last year following multiple cases.

Horrible...wheelchair bound for the rest of your life

First of all. Are you certain the test patient did not received a placebo jab? You posted an article that is based on speculation and incompleted investigation?
It is a clinical trial.

So Sinovac and Sinopharm is the same company and that is according to you.
so their vaccines are the same, right.

 

[Han Patriot]

Peru suspends Chinese Covid-19 vaccine trial over serious side effects

The National Institute of Health said a volunteer presented neurological symptoms, which could correspond to a condition called Guillain-Barre syndrome.

www.trtworld.com

Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.

The National Institute of Health said on Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.

"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.

Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs.

Peru declared a temporary health emergency in five regions in June last year following multiple cases.

Horrible...wheelchair bound for the rest of your life

Sinopharm is not Sinovac, you know this right? This comes after the facial paralysis of Pfitzer vaccines?

 

[sinait]

(Yicai Global) Dec. 15 -- Singapore recently signed an advance purchase agreement with Chinese vaccine maker Sinovac Biotech for Covid-19 vaccines, Singapore’s Lianhe Zaobao reported yesterday, but without detailing the number of shots to be supplied.

The Sinovac Biotech inoculants will arrive in batches next year, and Singapore is also in contact with other pharmaceutical companies, per the report.

Beijing-based Sinovac Biotech is promoting Phase III clinical trials of its inactivated vaccine CoronaVac against Covid-19 in Brazil, Indonesia, Turkey and Chile. Indonesia's state-owned pharma firm PT Bio Farma said this month that CoronaVac has proven 97 percent effective in early trials, and its ultimate efficacy rate will be determined next month.

The Sinovac Biotech jab was previously used in emergency inoculations against Covid-19 in Zhejiang in mid-October. On Dec. 7, Sinovac Biotech announced that it had obtained the results of Phase I/II clinical trials on an adult group and an elderly group in China, and started the Phase I/II clinical trials on a juvenile one.

Sinovac Biotech is expanding its production as these tests steadily advance. The firm’s Sinovac Life Sciences unit has secured over USD500 million from Sino Biopharmaceutical for further development, capacity expansion and manufacturing of its CoronaVac Covid-19 vaccine candidate, Sinovac Biotech announced on Dec. 7.

Sinovac Life Sciences has built and put into use a Covid-19 vaccine plant which is able to turn out 300 million vaccine doses annually, per the announcement. The company also plans to complete a second production line before year’s end and raise its annual output of CoronaVac to over 600 million doses.

Sinovac Biotech was China's first vaccine company to list in the US. Its shares [NASDAQ:SVA] rose 0.31 percent yesterday to USD6.47.

Singapore to Buy Covid Jab From China’s Sinovac Biotech

www.yicaiglobal.com

No Pfitzer vaccine for me.
I will take this Sinovac vaccine

Yuks, don't want to walk around looking like this.

.

 

[TaiShang]

No Pfitzer vaccine for me.
I will take this Sinovac vaccine

Yuks, don't want to walk around looking like this.
View attachment 697911
.

I won't, either.

Terrible although I Wish all vaccines will work.

World has production shortage already.

Western (US) vaccine fascism may hit them hardest, in fact.